NAA10 and BTRC drive CREBRF degradation in endoplasmic reticulum stress and renal tubular injury Authors: Sitian Fang, Jing Ning, Jinjing Huang, Yanxia Chen Published: 2026 ABSTRACT ABSTRACTBackgroundDiabetic kidney disease (DKD) is a frequent complication associated with diabetes. CREBRF was reported to be closely associated with endoplasmic reticulum stress. However, the upstream regulatory mechanism by which CREBRF modulates endoplasmic reticulum stress in DKD renal tubular injury is unknown.MethodsHK‐2 cells were treated with high glucose to construct a cellular model of DKD. C57BL/6J mice were injected intraperitoneally with streptozotocin (STZ) to construct an animal model of DKD. Co‐IP was employed to assess the interactions between BTRC or NAA10 and CREBRF, as well as the levels of CREBRF acetylation and ubiquitination. Flow cytometry, EdU, and CCK‐8 were used to detect apoptosis and proliferation. HE and PAS were performed to test renal histopathological changes. The expression of the above factors and endoplasmic reticulum stress‐related proteins was detected by western blot.ResultsCREBRF was downregulated in DKD, and overexpression of CREBRF inhibited endoplasmic reticulum stress to alleviate high glucose‐induced renal tubular injury. Additionally, NAA10 promoted acetylation of CREBRF, which facilitated BTRC‐mediated ubiquitination and degradation of CREBRF. Finally, NAA10 inhibited CREBRF to promote endoplasmic reticulum stress in high glucose‐induced renal tubules.ConclusionNAA10 promoted acetylation of CREBRF, which facilitated ubiquitination and degradation of CREBRF by BTRC, leading to activation of endoplasmic reticulum stress and exacerbation of renal tubular injury in DKD. Abbreviations beta‐transducin repeat containing Cell Counting Kit‐8 cycloheximide co‐immunoprecipitation cAMP response element binding protein 3 CREB3 regulatory factor diabetic kidney disease enhanced chemiluminescence enzyme‐linked immunosorbent assay hematoxylin–eosin immunohistochemistry N‐alpha‐acetyltransferase 10 periodic acid–Schiff polyvinylidene fluoride quantitative real‐time PCR streptozotocin thapsigargin INTRODUCTION Diabetic kidney disease (DKD) is the leading cause of kidney failure, affecting 30–40% of diabetic patients 1 . Studies have shown that DKD is a diabetes‐induced complication characterized by glomerular, tubular, and tubulointerstitial damage, which seriously jeopardizes patients' health 1 , 2 . However, there is still a gap in the clinical practice of effective treatment options for DKD. Renal tubular lesions are the main features of DKD, and renal tubular lesions can promote loss of renal function 3 , 4 . Notably, high glucose‐induced endoplasmic reticulum dysfunction contributes to renal tubular injury in DKD 4 . It has been indicated that endoplasmic reticulum stress in DKD renal tubules leads to apoptosis and necrosis of tubular cells, and inhibition of endoplasmic reticulum stress attenuates diabetic renal tubular injury 5 . Therefore, it is crucial to uncover the molecular mechanism that regulates renal tubular injury caused by endoplasmic reticulum stress in DKD. CREB3 regulatory factor (CREBRF) is an endoplasmic reticulum‐associated transmembrane protein through regulating cAMP response element binding protein 3 (CREB3) 6 . Importantly, CREBRF was strongly involved with endoplasmic reticulum stress. During endoplasmic reticulum stress, normal cells promote the upregulation of CREBRF to regulate the accumulation of unfolded proteins, which further maintains the homeostasis of the endoplasmic reticulum by regulating the activity of the endoplasmic reticulum stress‐related transcription factor CREB3 7 . Therefore, it was hypothesized that downregulation of CREBRF may lead to disruption of endoplasmic reticulum homeostasis. What's more, recent studies have found that CREBRF has multiple physiological functions in different diseases 8 , 9 , 10 . For example, CREBRF played a pro‐cancer role in cervical cancer 8 . Knockdown of CREBRF inhibited rheumatoid arthritis progression 9 . In addition, missense variants of CREBRF were strongly correlated with the risk of diabetes in Oceanian populations 10 , 11 . However, the relationship between CREBRF and DKD has not been reported, and how CREBRF regulates endoplasmic reticulum stress in DKD renal tubules needs to be further explored. Protein acetylation is a modification process in which the acetyl group is transferred to the polypeptide chain by acetyltransferases. Acetylation modification is essential for regulating protein stability and signaling pathways 12 . Numerous studies have shown that acetylation modification is closely related to DKD 13 , 14 . Du et al. 13 found that certain proteins were acetylated when renal tubular cells were stimulated with high glucose. Acetylation level of CREBRF protein was elevated, and total protein level was reduced in high glucose‐treated renal tubular epithelial cells 14 . However, this phenomenon has not been explored in depth, and the mechanism behind it is not clear. To explore the reasons for the upregulation of CREBRF acetylation levels, we found that the CREBRF protein has a protein interaction with the acetyltransferase N‐Alpha‐Acetyltransferase 10 (NAA10) through the Biogrid database. NAA10 regulated cellular physiological processes by mediating target protein acetylation modifications 15 , 16 , 17 . It was revealed that NAA10 promoted acetylation of target proteins to facilitate oxidative stress in cells 15 . In addition, mice with high expression of NAA10 were more susceptible to oxidative stress, which can lead to kidney and liver damage 16 . These pathological processes were primarily determined by the function of the target protein modified by NAA10 17 . However, whether NAA10 affects tubular endoplasmic reticulum stress in DKD by regulating the acetylation of CREBRF protein still needs to be further explored. Notably, acetylation modifications are often cross‐linked with other post‐translational modifications, such as the acetyltransferase p300/CBP‐related factor, which promoted HOXB9 ubiquitination and degradation by mediating acetylation of HOXB9 18 . Acetylation of BCAT2 resulted in its degradation through the ubiquitin‐proteasome pathway 19 . Moreover, the Genecard database suggested that CREBRF can be degraded by proteases. Therefore, we hypothesized that the downregulation of CREBRF may result from crosstalk between acetylation and ubiquitination modifications, but this mechanism has not been reported in DKD. This study aimed to reveal the molecular mechanism by which NAA10 regulates the post‐translational modification of CREBRF to affect renal tubular injury in DKD. In conclusion, this study elucidated that NAA10 regulated the acetylation of CREBRF to affect its ubiquitination. Downregulation of CREBRF activated endoplasmic reticulum stress in DKD, ultimately causing renal tubular injury. In addition, this work provides new diagnostic and therapeutic targets for DKD to overcome the current clinical treatment dilemma. MATERIALS AND METHODS Establishment of the animal model Twenty male C57BL/6J mice (6–8 weeks old) were obtained from SJA Laboratory Animal Co, Ltd (Changsha, China). The mice were acclimatized for a fortnight in an SPF‐grade environment (12‐h light/dark cycle). Subsequently, C57BL/6J mice were injected with 50 mg/kg streptozotocin (STZ, Sigma‐Aldrich, St. Louis, MO, USA) for five consecutive days. Control mice were injected with saline 20 . Then, kidney tissues, blood, and urine were collected. Tail vein blood glucose levels were detected using a blood glucose meter (Roche, Basel, Switzerland), and diabetic animal models were successfully constructed when blood glucose levels were ≥ 250 mg/dL. Urine protein concentrations were tested following the protocol provided with the test kit (Sangon, Shanghai, China). Animal experiments for this study were approved by the Animal Ethics Committee of Nanchang University. Hematoxylin–eosin (HE) staining Kidney tissues were fixed in paraformaldehyde, and subsequently, the tissues were embedded and sectioned. After the sections were deparaffinized, a hematoxylin staining solution (Beyotime, Shanghai, China) was applied to stain sections for 5 min. Then, 1% hydrochloric acid alcohol (Beyotime) was used to differentiate the sections, which were then stained with an eosin staining solution (Beyotime) for several seconds. The sections were then viewed and photographed under a microscope (Olympus, Tokyo, Japan). Periodic acid–Schiff (PAS) staining PAS staining kit (Biosharp, Hefei, China) was employed to detect renal tubular damage. The sections were first dewaxed and hydrated. 1% periodic acid was used to oxidize the sections for 3 min. Subsequently, Schiff's reagent was dripped onto the sections for staining. Hematoxylin stain was then employed for counterstaining. Gradient alcohol was employed for dehydration. Finally, the sections were sealed and photographed under a microscope (Olympus). Immunohistochemistry (IHC) The dewaxed sections were subjected to antigen repair by sodium citrate antigen repair solution. The sections were blocked with serum at 37°C. Then, the anti‐CREBRF antibody (1:2,000, ab253202, Abcam, Cambridge, MA, USA) was added to the sections and incubated overnight at 4°C. The next day, the secondary antibody (1:4,000, RGAR011, Proteintech, Wuhan, China) was incubated with the sections for 20 min, and DAB staining solution was used for staining. Nuclei were stained with hematoxylin. Finally, a microscope (Olympus) was employed to observe the sections. TUNEL staining The TUNEL Apoptosis Detection Kit (Beyotime) was employed for apoptosis assessment. Briefly, after the sections were deparaffinized, 20 μg/mL proteinase K was used to permeabilize the cells. Then, the 3% H2O2 solution was applied for blocking. Sections were incubated with biotin‐labeling solution. Streptavidin‐HRP was then employed to cover the tissues. Subsequently, DAB solution and hematoxylin stain were utilized to stain the cells. Finally, sealed sections were observed by a microscope (Olympus). ELISA assay A specific ELISA kit (Elabscience, Wuhan, China) was used to measure the level of KIM‐1, a marker of proximal tubular injury, in urine. Specifically, urine was first centrifuged for 20 min, and the supernatant was collected. Standards and samples were added to the enzyme plate separately, and then, the biotin antibody working solution was incubated with the above liquid at 37°C for 1 h. After the liquid in the wells was discarded, streptavidin‐HRP working solution was added to the wells. After 30 min, the substrate solution was added to the plate. The reaction was terminated after 15 min. Finally, a microplate reader (Thermo Fisher Scientific, Carlsbad, CA, USA) was used to measure the OD value of each well at 450 nm. Cell culture and treatment Human proximal renal tubular epithelial cell line (HK‐2) was acquired from American Type Culture Collection (ATCC). Cells were maintained in DMEM medium (Gibco, Grand Island, NY, USA) containing 5.5 mm glucose supplemented with 10% fetal bovine serum and penicillin–streptomycin. Subsequently, HK‐2 cells were treated with 30 mm high glucose (Sigma‐Aldrich) for 24 h to construct a DKD cell model. In addition, 0.1 μm thapsigargin (Tg, Sigma‐Aldrich) was added to induce endoplasmic reticulum stress in HG‐induced HK2 cells. Lentiviral packaging The vectors for overexpression of CREBRF and knockdown of NAA10 (sh‐NAA10), Beta‐transducin repeat containing (BTRC) (sh‐BTRC), and CREBRF (sh‐CREBRF) were purchased from GenePharma (Shanghai, China). The above plasmids were transfected into HEK293T cells. Subsequently, the viral liquid produced by the cells was purified and stored in a −80°C refrigerator. Lentiviral infection HK‐2 cells were inoculated in 24‐well plates. After cell confluence reached 60%, polybrene (Biosharp) was used to infect the corresponding lentiviruses (lv‐NC, lv‐CREBRF, lv‐sh‐NC, lv‐sh‐NAA10, lv‐sh‐BTRC, lv‐ CREBRF) into HK‐2 cells. Subsequently, 2 μg/mL puromycin (Thermo Fisher Scientific) was used to select stable cell lines. Cell Counting Kit‐8 (CCK‐8) assay HK‐2 cells were inoculated in 96‐well plates (4 × 103 cells/well). After the cells were intervened accordingly, 10 μL of CCK‐8 solution (Proteintech) was added to the 96‐well plates. The cells were then placed in a cell culture incubator to continue incubation for 3.5 h. Finally, the OD value of each well was determined at 450 nm using a microplate reader. EdU assay EdU assay was performed according to EdU Apollo 567 In Vitro kit (Solarbio, Beijing, China). Briefly, HK‐2 cells were subjected to the corresponding lentiviral infection and treatment. Cells were then incubated with 50 μm EdU for 2 h. After the cells were fixed, Apollo staining solution was added to the 96‐well plates for 30 min. Hoechst 33342 reaction solution was then employed to stain the DNA. Subsequently, the cell proliferation was observed by fluorescence microscopy (Olympus). Co‐immunoprecipitation (Co‐IP) assay Cells in each group were lysed with cell lysate, and the lysate mixture was subsequently centrifuged. The supernatant was added with anti‐BTRC antibody (37‐3400, Thermo Fisher Scientific), anti‐NAA10 antibody (14803‐1‐AP, Proteintech), or anti‐IgG antibody (ab172730, Abcam). The above fluids were incubated at 4°C overnight. The following day, protein A/G magnetic beads were added to each group of liquids and incubated for 1.5 h to form protein–antibody–magnetic bead complexes. Proteins were then eluted and denatured at 98°C. Finally, western blot was employed to analyze the interaction of NAA10 or BTRC with CREBRF protein. IP assay Anti‐CREBRF antibody (ab253202, Abcam) was added to cell lysates for overnight incubation. The following day, each group of fluid was further incubated with protein A/G magnetic beads. Subsequently, the protein on the beads was collected, and the level of acetylation of the CREBRF protein, as well as the level of ubiquitination, were assessed by western blot. CREBRF protein stability After HK‐2 cells were infected with lv‐sh‐NAA10, the cells were treated with 40 μg/mL cycloheximide (CHX, Sigma‐Aldrich) for 0, 2, 4, and 8 h. Subsequently, the cellular proteins were extracted. Finally, western blot was used to test the protein expression of CREBRF. Detection of apoptosis rate, ROS, and Ca2+ levels The Annexin V‐FITC/PI Apoptosis Kit (Dojindo, Kumamoto, Japan) was adopted to measure apoptosis. Briefly, HK‐2 cells were treated with lentivirus and high glucose. Subsequently, the cells were collected in centrifuge tubes. After the cells were resuspended with binding buffer, Annexin V‐FITC and PI were added to the cells and incubated for 10 min in the dark. Finally, flow cytometry (Thermo Fisher Scientific) was used to measure the apoptosis rate. Cellular ROS level was detected by the DCFH‐DA probe (Selleck Chemicals, Houston, TX, USA). Briefly, after the cells were collected, 1 mL of DCFH‐DA working solution was added to resuspend the cells. After 20 min, flow cytometry was implemented to assess ROS level. In addition, cellular Ca2+ level was detected by Fluo4‐AM probe (Beyotime) as described in the reagent manufacturer's instructions. Fluo‐4AM working solution was added to the cell sediment and incubated for 30 min. Then, cells were centrifuged, and the cell pellet was retained. Subsequently, PBS was adopted to resuspend the cells. Finally, Ca2+ level was examined using flow cytometry. Quantitative real‐time PCR (RT‐qPCR) Total RNA from HK‐2 cells was extracted using TRIzol reagent. RNA was reverse transcribed to cDNA by PrimeScript™ RT kit (TaKaRa, Tokyo, Japan). Real‐time quantitative PCR was performed using SYBR Green PCR premix kit (Thermo Fisher Scientific). The internal reference for this experiment was β‐actin. Relative RNA expression levels of CREBRF, NAA10, and BTRC were assessed by 2−ΔΔCt. Primers for this experiment were shown below (5′‐3′).CREBRF‐F: ACCCACTTCAAGCACACAAAT.CREBRF‐R: GGGTTGATCTTTACCTTTGCCT.NAA10‐F: GCGAGGCCAGAGGACCTAA.NAA10‐R: AGCCAATGAGGTGATATGTCCA.BTRC‐F: CCAGACTCTGCTTAAACCAAGAA.BTRC‐R: GGGCACAATCATACTGGAAGTG.β‐actin‐F: CCCTGGAGAAGAGCTACGAG.β‐actin‐R: CGTACAGGTCTTTGCGGATG. CREBRF‐F: ACCCACTTCAAGCACACAAAT. CREBRF‐F: ACCCACTTCAAGCACACAAAT. CREBRF‐R: GGGTTGATCTTTACCTTTGCCT. CREBRF‐R: GGGTTGATCTTTACCTTTGCCT. NAA10‐F: GCGAGGCCAGAGGACCTAA. NAA10‐F: GCGAGGCCAGAGGACCTAA. NAA10‐R: AGCCAATGAGGTGATATGTCCA. NAA10‐R: AGCCAATGAGGTGATATGTCCA. BTRC‐F: CCAGACTCTGCTTAAACCAAGAA. BTRC‐F: CCAGACTCTGCTTAAACCAAGAA. BTRC‐R: GGGCACAATCATACTGGAAGTG. BTRC‐R: GGGCACAATCATACTGGAAGTG. β‐actin‐F: CCCTGGAGAAGAGCTACGAG. β‐actin‐F: CCCTGGAGAAGAGCTACGAG. β‐actin‐R: CGTACAGGTCTTTGCGGATG. β‐actin‐R: CGTACAGGTCTTTGCGGATG. Western blot Total proteins from kidney tissues and HK‐2 cells were obtained by high‐efficiency RIPA lysate (Solarbio). Subsequently, proteins were quantified and denatured. SDS‐PAGE was utilized to separate proteins. Proteins were then transferred to PVDF membrane (Beyotime) and blocked with skimmed milk. The PVDF membranes were incubated with primary antibody overnight (4°C). After the primary antibody was discarded, the corresponding secondary antibody was added to the PVDF membrane and incubated for 2 h. Finally, the protein bands were visualized with ECL chemiluminescence kit. Primary antibodies used in this experiment included CREBRF (1:1,000, PA5‐68552, Thermo Fisher Scientific), GRP78 (1:1,000, ab108615, Abcam), p‐IRE1 (1:1,000, ab243665, Abcam), IRE1 (1:1,000, ab322061, Abcam), p‐PERK (1:1,000, #3179, Cell Signaling Technology, Danvers, MA, USA), PERK (1:1,000, ab79483, Abcam), CHOP (1:1,000, #5554, Cell Signaling Technology), NAA10 (1:1,000, ab155687, Abcam), and BTRC (1:1,000, ab233739, Abcam). All uncropped Western blot images and raw replicate data were shown (Supplementary file). Statistical analysis Statistical analyses were performed using GraphPad Prism 9 software (GraphPad Software, Inc., San Diego, CA, USA). The experiments were all repeated at least three times, and the results were expressed as mean ± standard deviation (SD). Comparisons between two and multiple groups were analyzed by t‐test and one‐way anova, respectively. P < 0.05 indicated statistical significance. RESULTS CREBRF was downregulated in DKD and associated with tubular injury To explore the role of CREBRF in DKD at the in vivo level, the diabetic mouse model was established, and the experimental groups were divided into NC and DM. It was revealed that the blood glucose level in the DM group was significantly elevated, exceeding 250 mg/dL (Figure 1a). In addition, the urinary protein level was also increased in the DM group of mice (Figure 1b). Moreover, renal tubules were severely damaged, glycogen deposition was increased (as assessed by PAS staining, showing intensely stained bright purple‐red cytoplasm compared with the lightly stained cytoplasm with sparse purple‐red granules in normal renal tubules), and interstitial damage scores were elevated in the DM group (Figure 1c). The level of KIM‐1, an indicator of renal tubular injury, was increased in DM mice (Figure 1d). Furthermore, it was also observed that the number of apoptotic cells increased in the kidney tissue of DM mice (Figure 1e). Additionally, CREBRF was decreased in DM and was mainly expressed in the cytoplasm (Figure 1f,g). The above results suggested that the downregulation of CREBRF may be associated with renal tubular injury in DKD. CREBRF was downregulated in DKD and associated with tubular injury. C57BL/6J mice were injected with STZ to construct an animal model of diabetes. Control mice were injected with saline. Animals were divided into: control (NC) group and model (DM) group. (a) Blood glucose meter was used to measure blood glucose levels in mice, and blood glucose concentrations >250 mg/dL were judged to be successful in model construction. (b) The kit was utilized to measure urine protein levels. (c) HE and PAS staining were employed to confirm renal tubular damage and to analyze the tubulointerstitial damage score. (d) Urinary KIM‐1 levels were examined by ELISA. (e) TUNEL staining was performed to assess apoptosis. (f) Changes in CREBRF expression and localization were evaluated by IHC. (g) Western blot was applied to measure the expression of CREBRF. N = 10, **P < 0.01, ***P < 0.001. Upregulation of CREBRF alleviated high glucose‐induced renal tubular injury To further investigate the role of CREBRF in high glucose‐induced renal tubular injury, high glucose was applied to treat HK‐2 cells. It was found that high glucose inhibited HK‐2 cell viability (Figure 2a) and downregulated CREBRF expression (Figure 2b). Subsequently, lv‐NC or lv‐CREBRF was transfected into high glucose‐induced cells. It was identified that overexpression of CREBRF rescued the high glucose‐induced downregulation of CREBRF (Figure 2c,d). Additionally, the upregulation of CREBRF reversed the inhibitory effect of high glucose treatment on HK‐2 cell function and increased cell viability and proliferation (Figure 2e,f). Overexpression of CREBRF reduced the apoptosis rate in the HG group (Figure 2g). Taken together, high glucose‐induced renal tubular injury was inhibited by upregulation of CREBRF. Upregulation of CREBRF alleviated high glucose‐induced renal tubular injury (a, b) HK‐2 cells were treated with high glucose for 24 h to construct in vitro high glucose‐induced renal tubular injury model, and the experimental groups were: normal glucose (NG) group and high glucose (HG) group. (a) CCK‐8 was employed to analyze cell viability after HK‐2 cells were treated with high glucose. (b) CREBRF expression was tested by western blot. (c–g) Lv‐NC or lv‐CREBRF were transfected into high glucose‐induced HK‐2 cells. (c, d) RT‐qPCR and western blot were applied to check the efficiency of overexpression of CREBRF. (e–g) CCK‐8, EdU, and flow cytometry were adopted to calculate cell viability, cell proliferation capacity, and apoptosis, respectively. N = 3, *P < 0.05, **P < 0.01, ***P < 0.001. Upregulation of CREBRF inhibited endoplasmic reticulum stress to rescue high glucose‐induced renal tubular injury To investigate whether CREBRF affects high glucose‐induced tubular injury by modulating endoplasmic reticulum stress, high glucose‐treated HK‐2 cells were overexpressed with CREBRF. It was shown that high glucose treatment significantly increased cellular ROS and Ca2+ levels, but overexpression of CREBRF weakened this phenomenon, which led to a decrease in ROS and Ca2+ levels (Figure 3a,b). In high glucose‐induced HK‐2 cells, GRP78, p‐IRE1, IRE1, p‐PERK, PERK, and CHOP were elevated. However, overexpression of CREBRF reversed the changes in the above protein levels (Figure 3c). Subsequently, high glucose‐induced cells were transfected with lv‐CREBRF and treated with Tg. Flow assay results demonstrated that addition of Tg reversed the downregulation of ROS and Ca2+ levels caused by overexpression of CREBRF (Figure 3d,e). Tg diminished the inhibitory effect of overexpression of CREBRF on the levels of GRP78, p‐IRE1, IRE1, p‐PERK, PERK, and CHOP (Figure 3f). The upregulation of CREBRF enhanced high glucose‐induced proliferation capacity, while inhibiting cell apoptosis. This phenomenon was impaired by Tg (Figure 3g,h). Collectively, upregulation of CREBRF alleviated high glucose‐induced renal tubular injury by inhibiting endoplasmic reticulum stress. Upregulation of CREBRF inhibited endoplasmic reticulum stress to rescue high glucose‐induced renal tubular injury (a–c) HK‐2 cells were treated with high glucose and were overexpressed with CREBRF. (a, b) ROS and Ca2+ levels were examined by flow cytometry. (c) Expression levels of GRP78, p‐IRE1, IRE1, p‐PERK, PERK, and CHOP were quantified by western blot. (d–h) High glucose‐induced HK2 cells were transfected to overexpress CREBRF and treated with Tg. (d, e) Flow cytometry was carried out to examine ROS and Ca2+ levels. (f) Western blot was performed to assess the expression of GRP78, p‐IRE1, IRE1, p‐PERK, PERK, and CHOP. (g, h) Proliferative capacity and apoptosis were checked by EdU and flow cytometry, respectively. N = 3, *P < 0.05, **P < 0.01, ***P < 0.001. NAA10 promoted acetylation of CREBRF and reduced its protein stability Importantly, it was reported that the level of acetylation of CREBRF protein was elevated in renal tubular epithelial cells treated with high glucose 14 . Meanwhile, our experimental results validated that the acetylation level of CREBRF was elevated in DKD animal models (Figure 4a). Subsequently, the upstream mechanism regulating the acetylation modification of CREBRF was explored. It was predicted that there was an interaction between NAA10 and CREBRF through the Biogrid database (Figure 4b). In addition, NAA10 was upregulated in both animal and cellular models of DKD (Figure 4c). Co‐IP results showed that anti‐NAA10 antibody significantly enriched CREBRF compared with anti‐IgG antibody, and this enrichment was greater in the DM and HG groups (Figure 4d). Then, lv‐sh‐NC or lv‐sh‐NAA10 was transfected into high glucose‐induced HK‐2 cells. Lv‐sh‐NAA10 significantly reduced the expression of NAA10 (Figure 4e,f). It was also noticed that the acetylation level of CREBRF decreased and the protein level increased after knockdown of NAA10 in high glucose‐induced HK‐2 cells (Figure 4g). Furthermore, knockdown of NAA10 significantly increased the protein stability of CREBRF (Figure 4h). The above data suggested that NAA10 mediated CREBRF acetylation through binding to CREBRF and that NAA10 was associated with CREBRF protein stability. NAA10 promoted acetylation of CREBRF and reduced its protein stability (a) IP was employed to determine the acetylation level of CREBRF in animal models of DKD. (b) The binding relationship between NAA10 and CREBRF was predicted by the Biogrid database. (c) NAA10 expression was assessed by western blot in DKD animal models. (d) Co‐IP was adopted to test the interactions between NAA10 and CREBRF in vivo and in vitro models of DKD. (e–h) High glucose‐induced HK2 cells were knocked down NAA10. (e, f) The knockdown effect of NAA10 was confirmed by RT‐qPCR and western blot. (g) Western blot and IP were deployed to examine the expression and acetylation levels of CREBRF. (h) After HK‐2 cells were treated with CHX, western blot was performed to assess the effect of knockdown of NAA10 on CREBRF protein stability. N = 10 or 3, *P < 0.05, **P < 0.01, ***P < 0.001. NAA10 promoted the ubiquitination and degradation of CREBRF by BTRC To further delve into the molecular mechanism by which NAA10 regulates CREBRF protein stability, high glucose‐induced HK2 cells were knocked down with NAA10. It was displayed that knockdown of NAA10 reduced ubiquitination of CREBRF (Figure 5a). In addition, the Biogrid database revealed that CREBRF interacted with BTRC (Figure 5b). BTRC was increased in kidney tissues and high glucose‐induced HK‐2 cells of DM mice (Figure 5c). Moreover, CREBRF protein bands were observed in the pull‐downs of the anti‐BTRC antibody, and the interactions between BTRC and CREBRF were stronger in the DM and HG groups (Figure 5d). Subsequently, high glucose‐induced HK‐2 cells were knocked down BTRC and the knockdown effect was verified (Figure 5e,f). Knockdown of BTRC significantly reduced the ubiquitination level of CREBRF and elevated its protein level (Figure 5g). Furthermore, Co‐IP assay results indicated that the interaction between CREBRF and BTRC weakened after knockdown of NAA10 (Figure 5h). In summary, NAA10 played a facilitating role in the process of BTRC‐mediated ubiquitination and degradation of CREBRF. NAA10 promoted the ubiquitination and degradation of CREBRF by BTRC (a) High glucose‐induced HK‐2 cells were transfected with lv‐sh‐NC or lv‐sh‐NAA10. The level of ubiquitination of CREBRF was evaluated by IP. (b) The Biogrid database was implemented to predict the binding relationship between CREBRF and BTRC. (c) BTRC expression was assayed by western blot in animal and cellular models of DKD. (d) After C57BL/6J mice were injected with STZ or HK‐2 cells were treated with high glucose, Co‐IP was deployed to test the interactions between BTRC and CREBRF. (e, f) RT‐qPCR and western blot were employed to verify the transfection efficiency of lv‐sh‐BTRC in high glucose‐induced HK‐2 cells. (g) In high glucose‐induced HK‐2 cells, western blot and IP were performed to examine CREBRF expression and ubiquitination levels after knockdown of BTRC. (h) Co‐IP was adopted to test the effect of knockdown of NAA10 on the binding relationship between BTRC and CREBRF in high glucose‐treated HK‐2 cells. N = 10 or 3, **P < 0.01, ***P < 0.001. NAA10 inhibited CREBRF to promote high glucose‐induced endoplasmic reticulum stress and injury in renal tubules To further study the role of the NAA10/CREBRF axis in DKD endoplasmic reticulum stress and injury at the in vitro level, HK‐2 cells were treated with high glucose and knocked down NAA10 and CREBRF. Lv‐sh‐CREBRF significantly reduced the level of CREBRF (Figure 6a,b). Furthermore, knockdown of NAA10 decreased ROS and Ca2+ levels in high glucose‐induced HK‐2 cells, whereas knockdown of CREBRF restored ROS and Ca2+ levels (Figure 6c,d). Levels of GRP78, p‐IRE1, IRE1, p‐PERK, PERK, and CHOP were downregulated after NAA10 was inhibited. However, knockdown of CREBRF reversed the above changes, leading to an increase in endoplasmic reticulum stress‐related proteins (Figure 6e). Knockdown of NAA10 elevated cell viability and proliferative capacity in high glucose‐induced cells, which was counteracted by further downregulation of CREBRF (Figure 6f,g). Furthermore, knockdown of CREBRF diminished the inhibition of apoptosis caused by knockdown of NAA10 (Figure 6h). The above results indicated that NAA10 promoted high glucose‐induced endoplasmic reticulum stress and injury in renal tubules by downregulating CREBRF. NAA10 inhibited CREBRF to promote high glucose‐induced endoplasmic reticulum stress and injury in renal tubules High glucose‐induced HK2 cells were knocked down by NAA10 and CREBRF. (a, b) CREBRF knockdown efficiency was checked by RT‐qPCR and western blot. (c, d) Flow cytometry was employed to measure ROS and Ca2+ levels. (e) Western blot was adopted to assess the expression of GRP78, p‐IRE1, IRE1, p‐PERK, PERK, and CHOP. (f–h) HK‐2 cell viability, cell proliferation, and apoptosis were evaluated by CCK‐8, EdU, and flow cytometry, respectively. N = 3, *P < 0.05, **P < 0.01, ***P < 0.001. DISCUSSION DKD is one of the chronic complications of diabetes and is the first factor leading to chronic kidney disease. In recent years, the incidence of DKD has been increasing rapidly, imposing a heavy burden on socioeconomic and human health 21 . Currently, the standard treatment for DKD includes controlling blood glucose and blood pressure, but this still fails to prevent disease progression and the associated increase in mortality 22 . Therefore, it is important to deeply investigate the pathogenic mechanism of DKD as well as to develop new strategies for the treatment of DKD. Renal tubules are thought to play a key role in the pathogenesis of DKD and are widely involved in the progressive decline of renal function 23 . Recent studies suggest that proximal renal tubules may play an initiating role in the early pathogenesis of renal disease 24 . Therefore, the search for new targets to inhibit renal tubular injury in DKD is imminent. In this work, we found that downregulation of CREBRF could activate endoplasmic reticulum stress in DKD, which in turn caused renal tubular injury. Mechanistically, NAA10 promoted the acetylation of CREBRF to facilitate the ubiquitination and degradation of CREBRF by BTRC, which ultimately leads to the downregulation of CREBRF protein level. Organelles play an irreplaceable role in maintaining cellular homeostasis. Organelle stress responses, particularly endoplasmic reticulum stress, are closely related to the pathophysiology of kidney diseases 25 . In DKD, inhibiting endoplasmic reticulum stress‐induced apoptosis in renal tubules alleviated DKD 13 . Furthermore, downregulation of endoplasmic reticulum stress‐related proteins GRP78, PERK, CHOP, and ATF6 significantly improved renal function in DKD 26 . In animal models of DKD, the expression of ER stress markers was increased 27 . The above studies suggested that inhibition of endoplasmic reticulum stress may be a key measure to attenuate renal tubular injury in DKD. CREBRF, a regulator of CREB3, has been reported to mediate the degradation of CREB3 28 . Downregulation of CREB3 induces endoplasmic reticulum stress and apoptosis in the nervous system 29 . The result of GO analysis also indicated that CREBRF could regulate endoplasmic reticulum stress. This implied that CREBRF promoted endoplasmic reticulum stress by regulating CREB3. Notably, Wan et al. 14 found that CREBRF was reduced in high glucose‐induced renal tubular epithelial cells. However, whether CREBRF can influence the progression of DKD by promoting endoplasmic reticulum stress has not been reported. This study was the first to find that CREBRF was downregulated in an animal model of DKD and upregulating CREBRF to inhibit endoplasmic reticulum stress to rescue high glucose‐induced tubular injury. Therefore, CREBRF may be an effective biological target for the treatment of DKD. Protein acetylation modification is closely related to DKD. A previous histological analysis showed that the acetylation modifications of many proteins were altered in DKD kidney tissues 30 . High glucose‐induced downregulation of Sirt1 increased YY1 acetylation in HK‐2 cells, and upregulation of YY1 deacetylation inhibited DKD progression 13 . Additionally, the level of acetylation of the CREBRF protein was elevated in high glucose‐treated renal tubular epithelial cells 14 . However, the upstream molecular mechanism that regulates the acetylation of CREBRF in DKD has not been reported. NAA10 is the catalytic subunit of the N‐terminal acetyltransferase complex NatA, exhibits Nα‐acetyltransferase activity, and catalyzes protein acetylation modifications 31 . For example, Hsp70 was rapidly acetylated by NAA10 in response to oxidative stress stimulation 17 . NAA10 directly acetylated NRF2 in colorectal cancer 32 . This work was the first to discover that NAA10 mediated CREBRF acetylation modification by binding to CREBRF in DKD. Importantly, acetylation modifications play a key role in protein stability. In neuroblastoma, promoting acetylation of the Cx32 protein led to enhanced stability of the Cx32 protein 33 . Yang et al. 34 found that acetylation modification of α‐catenin enhanced its protein stability in breast cancer. However, the relationship between NAA10‐mediated acetylation of CREBRF and CREBRF protein stability has not been reported. In this study, we further found that knockdown of NAA10 reduced the ubiquitination level of CREBRF and weakened its interaction with the E3 ubiquitin ligase BTRC, whereas knockdown of BTRC similarly decreased CREBRF ubiquitination and increased its protein level. These results indicate that NAA10 promotes CREBRF acetylation, thereby enhancing its binding to BTRC and facilitating its ubiquitination and degradation. There is crosstalk between different types of protein post‐translational modifications 35 , for example, ACAT1‐mediated acetylation of GLDC triggered polyubiquitination of GLDC by the ubiquitin ligase NF‐X1, which led to degradation of GLDC by the proteasome pathway 36 . In 293 T cells, acetylation of GATA‐1 led to its ubiquitination which in turn reduced GATA‐1 protein stability 37 . However, whether NAA10‐mediated acetylation of CREBRF can regulate its ubiquitination modification to affect CREBRF protein stability has not been reported. In this study, bioinformatics analysis revealed that CREBRF interacted with the E3 ubiquitin protein ligase BTRC. BTRC promotes substrate ubiquitination and degradation by binding to the substrate. For example, in breast cancer, upregulation of BTRC enhanced ubiquitination and degradation of TFEB 38 . Zhou et al. 39 found that BTRC mediated CDH1 degradation. Furthermore, BTRC was upregulated in diabetic endothelial cells and promoted Twist1 ubiquitination to cause cellular damage 40 . In the present research, we found for the first time that NAA10 promoted ubiquitination and degradation of CREBRF by BTRC, which was consistent with related studies. Moreover, a previous study indicated that upregulation of NAA10 promoted oxidative stress thereby contributing to renal injury 16 . In the present study, we revealed that NAA10 inhibited CREBRF to promote endoplasmic reticulum stress and injury in high glucose‐induced renal tubules, confirming the role of the NAA10/CREBRF axis in renal tubular injury in DKD. In summary, this work revealed a novel pathway to control endoplasmic reticulum stress in DKD renal tubular injury. Specifically, the study observed that NAA10 mediated CREBRF acetylation, which promotes BTRC‐mediated ubiquitination of CREBRF to downregulate CREBRF, thereby promoting endoplasmic reticulum stress and exacerbating renal tubular injury in DKD. This study indicated that targeting CREBRF, NAA10, and BTRC may provide a promising strategy for the prevention and treatment of DKD. DISCLOSURE The authors declare no conflict of interest. Approval of the research protocol: Animal experiments for this study were approved by the Animal Ethics Committee of Nanchang University. Informed consent: N/A. Registry and the registration no. of the study/trial: N/A. Animal studies: N/A. Supporting information Data S1.All original Western blot images from the replicate experiments.